文献速递头颈外科

血锰与头颈部鳞状细胞癌风险

Blood Manganese and Risk of Squamous Cell Carcinomas of the Head and Neck.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2026-01-01

结果显示,遗传预测的较高血锰与口腔鳞癌(OR 1.25)及HPV阳性口咽鳞癌(OR 1.23)风险显著相关,其余亚型方向一致但无统计学意义。

要点

  • 遗传预测血锰每升高1个标准差,口腔鳞癌风险OR为1.25(95%CI 1.10-1.43,P<.001)。
  • HPV阳性口咽鳞癌风险OR为1.23(95%CI 1.04-1.45,P=.02),与血锰显著相关。
  • HPV阴性口咽、下咽及喉鳞癌关联方向一致但无统计学意义。

核心结论

  • 遗传预测的较高血锰浓度与口腔鳞癌及HPV阳性口咽鳞癌风险存在显著关联。

研究设计与样本

  • 基于人群的两样本顺式孟德尔随机化研究,血锰遗传工具来自6564名斯堪的纳维亚参与者的全基因组关联研究荟萃分析。

主要发现

  • 每1-SD血锰升高对应口腔鳞癌OR 1.25(95%CI 1.10-1.43,P<.001)。
  • 每1-SD血锰升高对应HPV阳性口咽鳞癌OR 1.23(95%CI 1.04-1.45,P=.02)。
  • HPV阴性口咽鳞癌OR 1.20(95%CI 0.95-1.50,P=.13)、下咽鳞癌OR 1.25(95%CI 0.75-2.07,P=.39)、喉鳞癌OR 1.10(95%CI 0.92-1.32,P=.28)无统计学意义。

临床怎么用

  • 结果提示血锰可能是口腔鳞癌及HPV阳性口咽鳞癌的可干预风险标志,但尚需机制研究支持公共卫生预防策略。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Squamous cell carcinomas of the oral cavity (OCSCC), oropharynx (OPSCC), hypopharynx (HPSCC), and larynx (LSCC) are the most common forms of head and neck cancer globally. Epidemiological studies have identified variations in blood trace metal concentrations as potential risk factors for the development of these cancers, but these studies are susceptible to multiple biases. OBJECTIVE: To determine if variations in genetically predicted blood manganese are associated with risk of OCSCC, OPSCC, HPSCC, and LSCC. DESIGN, SETTING, AND PARTICIPANTS: This population-based 2-sample cis-mendelian randomization study used a genetic instrument for blood manganese derived from a meta-analysis of 3 individual-level genome-wide association study datasets of 6564 Scandinavian participants. Genetic associations for the development of the specified cancers were obtained from a nonoverlapping, multi-ancestral meta-analysis that combined individual-level genome-wide association study datasets comprising 38 857 healthy controls, 5596 case patients with OCSCC, 2212 case patients with human papillomavirus (HPV)-positive OPSCC, 1473 case patients with HPV-negative OPSCC, 898 case patients with HPSCC, and 4409 case patients with LSCC. EXPOSURES: Increases in genetically predicted whole blood manganese concentration proxied by a genetic instrument including 2 cis-variants (single-nucleotide variants) selected due to their known functions in regulating manganese metabolism. MAIN OUTCOMES AND MEASURES: The primary outcomes were the risk of OCSCC, OPSCC (HPV positive and HPV negative), HPSCC, and LSCC, evaluated by estimating the odds ratio (OR) and 95% CI of each outcome per 1-SD increase in whole blood manganese concentration after rank-based inverse normalization transformation. RESULTS: Genetically predicted higher blood manganese was found to have a statistically significant association with increased risk of OCSCC (OR, 1.25; 95% CI, 1.10-1.43; P < .001) and HPV-positive OPSCC (OR, 1.23; 95% CI, 1.04-1.45; P = .02). Associations between blood manganese and HPV-negative OPSCC (OR, 1.20; 95% CI, 0.95-1.50; P = .13), HPSCC (OR, 1.25; 95% CI, 0.75-2.07; P = .39), and LSCC (OR, 1.10; 95% CI, 0.92-1.32; P = .28) were directionally concordant but not statistically significant. CONCLUSIONS AND RELEVANCE: This cis-mendelian randomization study demonstrates statistically significant associations between higher blood manganese concentrations and risk of OCSCC and HPV-positive OPSCC. Further work should aim to establish the pathophysiological mechanisms underlying this association to inform potential public health strategies for the prevention of these cancers.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Clay B, Bashir N, Burgess S, et al. Blood Manganese and Risk of Squamous Cell Carcinomas of the Head and Neck. JAMA Otolaryngol Head Neck Surg. 2026. PMID: 42390852. doi:10.1001/jamaoto.2026.1749

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。